Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29526 - 29550 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	DMRTB1	63948	upregulated	decitabine results in increased expression of DMRTB1 mRNA	1p32.3	A21915
Decitabine	Approved Investigational	DNAJA4	55466	upregulated	decitabine results in increased expression of DNAJA4 mRNA	15q25.1	A21915
Decitabine	Approved Investigational	DNAJB3	414061	upregulated	decitabine results in increased expression of DNAJB3 mRNA	2q37.1	A21915
Decitabine	Approved Investigational	DNAJC12	56521	downregulated	decitabine results in decreased expression of DNAJC12 mRNA	10q21.3	A20985
Decitabine	Approved Investigational	DNMT1	1786	downregulated	decitabine results in decreased expression of DNMT1 mRNA	19p13.2	A20778 A21965 A21966 A21967 A21623
Decitabine	Approved Investigational	DNMT1	1786	upregulated	decitabine results in increased expression of DNMT1 mRNA	19p13.2	A21968
Decitabine	Approved Investigational	DNMT3A	1788	downregulated	decitabine results in decreased expression of DNMT3A mRNA	2p23.3	A21966
Decitabine	Approved Investigational	DNMT3B	1789	downregulated	decitabine results in decreased expression of DNMT3B mRNA	20q11.21	A21966 A21922 A21918
Decitabine	Approved Investigational	DOK1	1796	upregulated	decitabine results in increased expression of DOK1 mRNA	2p13.1	A21915
Decitabine	Approved Investigational	DOK4	55715	upregulated	decitabine results in increased expression of DOK4 mRNA	16q21	A21917
Decitabine	Approved Investigational	DPYD	1806	upregulated	decitabine results in increased expression of DPYD mRNA	1p21.3	A21969
Decitabine	Approved Investigational	DSPP	1834	upregulated	decitabine results in increased expression of DSPP mRNA	4q22.1	A21915
Decitabine	Approved Investigational	DUSP6	1848	upregulated	decitabine results in increased expression of DUSP6 mRNA	12q21.33	A21912
Decitabine	Approved Investigational	DYNLL1	8655	upregulated	decitabine results in increased expression of DYNLL1 mRNA	12q24.31	A21912
Decitabine	Approved Investigational	E2F6	1876	downregulated	decitabine results in decreased expression of E2F6 mRNA	2p25.1	A20985
Decitabine	Approved Investigational	EBI3	10148	upregulated	decitabine results in increased expression of EBI3 mRNA	19p13.3	A21919
Decitabine	Approved Investigational	EEF1A2	1917	upregulated	decitabine results in increased expression of EEF1A2 mRNA	20q13.33	A21919
Decitabine	Approved Investigational	EGFL7	51162	upregulated	decitabine results in increased expression of EGFL7 mRNA alternative form	9q34.3	A20408
Decitabine	Approved Investigational	EGFR	1956	upregulated	decitabine results in increased expression of EGFR mRNA	7p11.2	A21912
Decitabine	Approved Investigational	EGR1	1958	upregulated	decitabine results in increased expression of EGR1 mRNA	5q31.2	A21915
Decitabine	Approved Investigational	EIF4G1	1981	upregulated	decitabine results in increased expression of EIF4G1 mRNA	3q27.1	A21917
Decitabine	Approved Investigational	ELAVL3	1995	upregulated	decitabine results in increased expression of ELAVL3 mRNA	19p13.2	A21915
Decitabine	Approved Investigational	ENO1	2023	upregulated	decitabine results in increased expression of ENO1 mRNA	1p36.23	A21917
Decitabine	Approved Investigational	ENOX1	55068	downregulated	decitabine results in decreased expression of ENOX1 mRNA	13q14.11	A21913
Decitabine	Approved Investigational	EPHA1	2041	upregulated	decitabine results in increased expression of EPHA1 mRNA	7q34-q35	A21970

Displaying entries 29526 - 29550 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability